Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Tanaka

Showing results (321-330 of 349) with videos related to

Pageof 35
Sort By:
Cell Reports|May 24, 2018
Regulation of Pathogenic T Helper 17 Cell Differentiation by Steroid Receptor Coactivator-3Kentaro Tanaka, Gustavo J Martinez, Xiaowei Yan, et al.
Journal for Immunotherapy of Cancer|February 19, 2020
Propensity score-weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non-small cell lung cancer (WJOG10217L)Ryoji Kato, Hidetoshi Hayashi, Yasutaka Chiba, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2026
Rifaximin Improves Cognitive Performance and Reduces Cirrhosis-Related Adverse Events in Covert Hepatic Encephalopathy: A Randomized Controlled TrialHiroki Inada, Toshinori Toyota, Haruki Uojima, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 20, 2019
Day-to-day blood pressure variability is associated with lower cognitive performance among the Japanese community-dwelling oldest-old population: the SONIC studyKayo Godai, Mai Kabayama, Yasuyuki Gondo, et al.
Nature Communications|March 23, 2025
Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLCKentaro Tanaka, Jun Sugisaka, Yoshimasa Shiraishi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 25, 2022
Prevention of Contrast-Induced Nephropathy After Cardiovascular Catheterization and Intervention With High-Dose Strong Statin Therapy in Japan - The PREVENT CINC-J StudyMakoto Watanabe, Kazutaka Aonuma, Toyoaki Murohara, et al.
Molecular Cancer|October 29, 2025
IFITM3-MET interaction drives osimertinib resistance through AKT pathway activation in EGFR-mutant non-small cell lung cancerRitsu Ibusuki, Eiji Iwama, Atsushi Shimauchi, et al.
Science Translational Medicine|December 14, 2022
Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancerKentaro Tanaka, Kenji Chamoto, Sho Saeki, et al.
The Journal of Clinical Investigation|December 24, 2024
A conserved human CD4+ T cell subset recognizing the mycobacterial adjuvant trehalose monomycolateYuki Sakai, Minori Asa, Mika Hirose, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 31, 2024
Impact of radiotherapy-related late toxicities of skin and soft tissue in the neck on quality of life in head and neck cancer patients: a multi-institutional observational study in JapanTakuya Higashino, Masashi Wakabayashi, Sadamoto Zenda, et al.
Pageof 35

Showing results (321-330 of 349) with videos related to

Sort By:
Pageof 35
Cell Reports|May 24, 2018
Regulation of Pathogenic T Helper 17 Cell Differentiation by Steroid Receptor Coactivator-3Kentaro Tanaka, Gustavo J Martinez, Xiaowei Yan, et al.
Journal for Immunotherapy of Cancer|February 19, 2020
Propensity score-weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non-small cell lung cancer (WJOG10217L)Ryoji Kato, Hidetoshi Hayashi, Yasutaka Chiba, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2026
Rifaximin Improves Cognitive Performance and Reduces Cirrhosis-Related Adverse Events in Covert Hepatic Encephalopathy: A Randomized Controlled TrialHiroki Inada, Toshinori Toyota, Haruki Uojima, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 20, 2019
Day-to-day blood pressure variability is associated with lower cognitive performance among the Japanese community-dwelling oldest-old population: the SONIC studyKayo Godai, Mai Kabayama, Yasuyuki Gondo, et al.
Nature Communications|March 23, 2025
Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLCKentaro Tanaka, Jun Sugisaka, Yoshimasa Shiraishi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 25, 2022
Prevention of Contrast-Induced Nephropathy After Cardiovascular Catheterization and Intervention With High-Dose Strong Statin Therapy in Japan - The PREVENT CINC-J StudyMakoto Watanabe, Kazutaka Aonuma, Toyoaki Murohara, et al.
Molecular Cancer|October 29, 2025
IFITM3-MET interaction drives osimertinib resistance through AKT pathway activation in EGFR-mutant non-small cell lung cancerRitsu Ibusuki, Eiji Iwama, Atsushi Shimauchi, et al.
Science Translational Medicine|December 14, 2022
Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancerKentaro Tanaka, Kenji Chamoto, Sho Saeki, et al.
The Journal of Clinical Investigation|December 24, 2024
A conserved human CD4+ T cell subset recognizing the mycobacterial adjuvant trehalose monomycolateYuki Sakai, Minori Asa, Mika Hirose, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 31, 2024
Impact of radiotherapy-related late toxicities of skin and soft tissue in the neck on quality of life in head and neck cancer patients: a multi-institutional observational study in JapanTakuya Higashino, Masashi Wakabayashi, Sadamoto Zenda, et al.
Pageof 35